Is there a role for the development of a supra-regional network for the management of penile cancer in the Republic of Ireland?. Issue 2 (April 2016)

• Record Type: Journal Article
• Authors: Davis, N.F.; Fitzgerald, M.; Burke, J.P.; Breen, K.J.; Elamin, S.; Brady, C.M.; Power, D.G.; Hegarty, P.K.; Sweeney, P.
• Is Part Of: Surgeon. Volume 14:Issue 2(2016)
• Page Start: 82
• Page End: 86
• Publication Date: 2016-04
• Subjects: Penile cancer -- Centralisationm -- Urology -- Supra-regional network -- Cancer specific survival -- Recurrence free survival; Surgery -- Periodicals; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; 617
• DOI: 10.1016/j.surge.2014.07.006
• Languages: English
• ISSNs: 1479-666X

Abstract

Abstract: Introduction: There is an average of 25 cases of penile cancer in the Republic of Ireland each year. Due to the low volume of cases, the National Institute for Clinical Excellence recommends that treatment is centralised to allow the best standardised treatment for primary tumours and nodal disease. Objectives: To determine whether outcomes for patients with penile cancer differed significantly between secondary and tertiary referral centres in the Republic of Ireland. Methods: Between 2001 and 2014, 36 patients were treated in the Mercy University Hospital (MUH) with penile cancer. Twenty patients were treated primarily in MUH and 16 patients underwent initial management in a secondary referral centre (SRC) with subsequent referral to the MUH. A retrospective matched case-control study was performed on this patient cohort. Results: There were no significant differences in length of follow-up or risk factors for the development of penile cancer between both groups ( p = 0.6 and p = 0.5 respectively) Ultimately, the incidence of high risk disease, nodal metasases, high grade disease and pelvic lymph node dissection were significantly greater in patients that were initially managed in a SRC ( p = 0.02, p = 0.03, p = 0.004 and p = 0.028 respectively). Patients undergoing initial treatment in a SRC had a non-significantly reduced rate of cancer specific survival (88 Vs 66%, MUH Vs SRCs, p = 0.495) and recurrence free survival (85 Vs 46%, MUH Vs SRCs, p = 0.24). Conclusion: Our findings suggest that managing penile cancer in special interest centres may improve oncological outcome.